B-12 is redefining early-stage drug discovery with an AI copilot for chemists. Acting like a GPS for chemistry, B-12 helps pharma companies plan the recipes for new drugs—reducing timelines from years to just months. Their platform has already run paid pilots with major pharmaceutical companies, planning experiments that achieved full conversion in a single attempt, eliminating the usual 8-12 iteration cycle. The team’s pedigree is equally impressive: Andres built the first autonomous AI agent for molecular design (published in Nature Machine Intelligence with 750+ citations), while Zlatko is a 3x National Chemistry Olympiad champion and medicinal chemist with experience at Roche and top lab robotics companies. Backed by Y Combinator (S25), B-12 is publishing groundbreaking research in Nature to further validate their AI’s potential to transform drug discovery.

We designed a pitch deck that highlights B-12’s problem-solution fit, scientific credibility, and massive market potential crafted to capture investor attention and pharma partnerships.

Looking to tell your startup’s story as powerfully as B-12? Let’s design a pitch deck that makes your breakthrough impossible to ignore.